The CDC Foundation today announced a donation of $50,000 from Walgreens as the first gift to the Foundation’s Ending the HIV Epidemic Fund.

Following last year’s impactful collaboration between Walgreens and the CDC Foundation addressing the Zika outbreak, the two organizations are once again working together to help address another public health challenge—HIV prevention. To help extend the CDC Foundation’s important research and demonstration project, Walgreens made a donation today to help fund the CDC Foundation’s Sustainable Healthcenter Implementation PrEP Pilot (SHIPP) study.

To perform Human Herpesvirus-8 (HHV-8) diagnostics on specimens from a UCSF study on antiretroviral therapy for patients with AIDS and Kaposi’s sarcoma in Uganda.

To understand the rectal muscosal effects of cross-sex hormone therapy among U.S. and Thai transgender woman.

To investigate long-acting PrEP formulations in macaque subjects.

To learn lessons about how best to incorporate the delivery of daily oral pre-exposure prophylaxis (PrEP) into the services provided by health centers serving sexually active adults at high risk of acquiring HIV infection. The pilot study will initiate data collection at federally-qualified health centers (FQHCs) or look-alikes in four U.S. cities.

To help CDC increase understanding of the effectiveness of using maternal tenofovir containing combination drug during the second and third trimesters of pregnancy for the prevention of mother-to-child transmission of HIV and HBV in co-infected mothers.

To evaluate a topical HIV prevention product using a nonhuman primate, repeat low dose model to define activity and toxicity of an intravaginal ring product.

To investigate the biocompatibility, the drug release profile and length of prophylactic efficacy of a biodegradable subcutaneous implant containing antiretroviral drug(s), developed by RTI.

To conduct a study to assess the feasibility of a combination HIV preventive intervention with and without daily Truvada PrEP for HIV uninfected young men who have sex with men in Bangkok, Thailand.

To facilitate formation of a Clinical Trials Unit for HIV/AIDS and tuberculosis research to advance therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.

To evaluate a polymer-based in-situ forming implant and its ability to provide long-lasting protection against HIV infection.

To leverage social media to educate communities about the benefits of Syringe Services Programs, dispel misinformation and garner support at a grassroots level. Syringe Services Programs can support communities by offering services such as testing for HIV and other infectious diseases, clean needles, and connection to treatment upon request.